News Archives - The Ruesch Center for the Cure of Gastrointestinal Cancers

Third-Line Treatment Strategy in mCRC Shifts Focus From Tumor Response to Disease Stabilization

Benjamin A. Weinberg, MD, FACP, discusses the specific therapeutic goals and challenges of third-line metastatic colorectal cancer management.

Category: News

Colorectal cancer is rising in younger adults. Here’s who is most at risk and symptoms to watch for

“We’re now starting to see more and more people in the 20-, 30- and 40-year-old range developing colon cancer. At the beginning of my career, nobody that age had colorectal cancer,” said Dr. John Marshall., who has been a cancer doctor for more than three decades. That trend “is shaking us all, to be blunt,” said Marshall.

Category: News

Colorectal Cancer Now Leading Cause of Cancer Death in People Younger Than 50 According to New JAMA Report

“I’ve been doing this for 34 years. At the beginning of my career, there were really no patients under the age of 50, apart from an occasional inherited syndrome,” Dr. Marshall said. “I live in a fairly young city, and now approximately half of my patients are under the age of 50” said John Marshall, MD.

Category: News

Archive: News

Third-Line Treatment Strategy in mCRC Shifts Focus From Tumor Response to Disease Stabilization

Colorectal cancer is rising in younger adults. Here’s who is most at risk and symptoms to watch for

Colorectal Cancer Now Leading Cause of Cancer Death in People Younger Than 50 According to New JAMA Report

Recognizing How Treatment Differs in Community Setting for CRC

MATTERHORN, ATOMIC, CHALLENGE, and More

Discover how genetic testing can help identify these rare treatment targets

EXPEL-PANC trial combining BXCL701 + pembrolizumab in 2nd-line advanced Pancreatic Cancer

Excersise and Colorectal Cancer

Prognostic and Predictive Role of Circulating Tumor DNA (ctDNA) in Stage III Colon Cancer Treated With Celecoxib:

‘Bad’ Gut Bacteria Tied to Colorectal Cancer in Younger Adults